Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPH3348 Food Effect Study in Healthy Chinese Subjects
NCT06652997Phase 1Completed
- Sponsor
- West China Second University Hospital
- Start
- Jul 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of SPH3348 in solid tumor (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration at 3 hours and 1 more. Started Jul 2022; status: completed.
02
Drugs
SPH3348
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06652997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06652997.